Soluble epoxide hydrolase inhibitor

• UNSPSC Description:

  Soluble epoxide hydrolase inhibitor is an inhibitor of soluble epoxide hydrolase, and inhibits human soluble epoxide hydrolase (h-sEH) with pIC50 of 8.4, extracted from patent WO 2010096722 A1, example 57.

• Target Antigen:

  Epoxide Hydrolase

• Type:

  Reference compound

• Related Pathways:

  Metabolic Enzyme/Protease

• Applications:

  Metabolism-sugar/lipid metabolism

• Field of Research:

  Metabolic Disease; Cardiovascular Disease

• Assay Protocol:

  https://www.medchemexpress.com/Soluble_epoxide_hydrolase_inhibitors.html

• Solubility:

  10 mM in DMSO

• Smiles:

  O=C(C1=CN2C(C=C1)=NN(CC(F)F)C2=O)NCC3=CC=C(C#N)C=C3OC(F)(F)F

• Molecular Weight:

  441.31

• References & Citations:

  [1]3-OXO-2, 3-DIHYDRO- [1,2, 4] TRIAZOLO [4, 3-A]PYRIDINES AS SOLUBLE EPOXIDE HYDROLASE (SEH) INHIBITORS. WO 2010096722 A1

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  1241826-88-9